Stock of the Day for December 10, 2024

Thermo Fisher Scientific Stock Report

Thermo Fisher Scientific
TMO 90-day performance NYSE:TMO Thermo Fisher Scientific
Current Price
$488.65
+0.46 (+0.09%)
(As of 04/7/2026 03:59 PM ET)
30 Day Performance
-4.24%
  
  
90 Day Performance
-19.39%
  
  
1 Year Performance
17.02%
  
 
Market Capitalization
$181.52B
P/E Ratio
27.54
Dividend Yield
0.38%

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies. Customers span academic and government research institutions, pharmaceutical and biotech firms, hospitals and clinical labs, and industrial and environmental testing organizations. The company’s product portfolio ranges from benchtop tools and reagents to high-end mass spectrometers, genomic sequencing platforms, and bioprocessing systems used in drug development and manufacturing.

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific was formed through the 2006 combination of Thermo Electron and Fisher Scientific and has since grown its global footprint through organic investment and strategic acquisitions, including notable transactions that expanded its molecular and bioproduction capabilities. The company maintains operations and sales across North America, Europe, Asia-Pacific and other international markets, supporting a global customer base.

Thermo Fisher is led by an executive team responsible for overseeing its diverse portfolio and global operations; the company emphasizes innovation, regulatory compliance and customer services as core components of its strategy to serve life science research, clinical diagnostics and industrial markets.

TMO Company Calendar

DEC. 15, 2025
Ex-Dividend for 1/15 Dividend
JAN. 15, 2026
Dividend Payable
JAN. 29, 2026
Last Earnings
MAR. 13, 2026
Ex-Dividend for 4/15 Dividend
APR. 8, 2026
Today
APR. 15, 2026
Dividend Payable
APR. 23, 2026
Next Earnings (Confirmed)
DEC. 31, 2026
Fiscal Year End

Recent Thermo Fisher Scientific News

TMO Stock May Benefit From New Gibco CTS Portfolio Addition
Thermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC
JB Capital LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO
This report was written by MarketBeat.com on April 8, 2026. This report first appeared on MarketBeat.com.